Screening for chronic obstructive pulmonary disease

JAMA - Journal of the American Medical Association

Volumn 318, Issue 17, 2017, Pages 1702-1703

  Press, Valerie G ^a   Cifu, Adam S ^a   White, Steven R ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN DEFICIENCY; CHEST INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL OUTCOME; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SCREENING; SHORT SURVEY; SMOKING CESSATION; SPIROMETRY; SYMPTOM; EVIDENCE BASED MEDICINE; MASS SCREENING; PRACTICE GUIDELINE;

ALPHA 1-ANTITRYPSIN DEFICIENCY; EVIDENCE-BASED MEDICINE; HUMANS; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY;

EID: 85034661521     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.15782     Document Type: Short Survey

References (9)

1. National Institutes of Health. Chronic obstructive pulmonary disease (COPD) fact sheet. https://report.nih.gov/nihfactsheets/ViewFactSheet.aspx?csid=77. Accessed April 16, 2017.
2. Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB. Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: Summary of the Evidence for the US Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2008. https://www.ncbi.nlm.nih.gov/books /NBK33976/. Accessed April 16, 2017.
3. Labonté LE, Tan WC, Li PZ, et al; Canadian Respiratory Research Network; CanCOLD Collaborative Research Group. Undiagnosed chronic obstructive pulmonary disease contributes to the burden of health care use: data from the CanCOLD Study. Am J Respir Crit Care Med. 2016; 194(3):285-298.
4. Woodruff PG, Barr RG, Bleecker E, et al; SPIROMICS Research Group. Clinical significance of symptoms in smokers with preserved pulmonary function. N Engl J Med. 2016;374(19):1811-1821.
5. Siu AL, Bibbins-Domingo K, Grossman DC, et al; US Preventive Services Task Force. Screening for chronic obstructive pulmonary disease: US Preventive Services Task Force recommendation statement. JAMA. 2016;315(13):1372-1377.
6. GOLD 2017 Global Strategy for the Diagnosis, Management and Prevention of COPD. http://goldcopd.org/gold-2017-global-strategy -diagnosis-management-prevention-copd/. Accessed March 12, 2017.
7. Qaseem A, Wilt TJ, Weinberger SE, et al; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179-191.
8. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ. 1997;75(5):397-415.
9. Au DH. Screening for chronic obstructive pulmonary disease: D is the new F. JAMA Intern Med. 2016;176(5):601-602.